Quantcast
Channel: WN.com - Articles related to MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and Approval of Share Issuances
Viewing all articles
Browse latest Browse all 300

MELA Sciences Initiates First Study to Investigate Real-World Clinical Impact of the MelaFind System on ...

$
0
0
IRVINGTON, N.Y., June 3, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the United States and the European Union to assist dermatologists in melanoma diagnosis, today announced that it has initiated a study to examine the real-world clinical impact of MelaFind on dermatologists' decision to biopsy pigmented skin lesions that are suspicious for melanoma. Darrell Rigel, MD, MS, Clinical Professor of Dermatology at New York University Langone Medical Center, will be the Principle Investigator for the study. Rose Crane, MELA Sciences President and CEO, commented, "This trial is significant as...

Viewing all articles
Browse latest Browse all 300

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>